Clinical trials
Phase 2/3 Small Cell Lung Carcinoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2009 | 1 |
| 2015 | 1 |
| 2017 | 2 |
| 2019 | 2 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Unknown status | 4 |
| Not yet recruiting | 2 |
| Active, not recruiting | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Changzhou Cancer Hospital of Soochow University | 1 |
| Charite University, Berlin, Germany | 1 |
| Chinese PLA General Hospital | 1 |
| Fuda Cancer Hospital, Guangzhou | 1 |
| Haihe Biopharma Co., Ltd. | 1 |
| Han Xu, M.D., Ph.D., FAPCR, Medical Director,, IRB Chair | 1 |
| Intergroupe Francophone de Cancerologie Thoracique | 1 |
| Peking Union Medical College Hospital | 1 |
| Pfizer | 1 |
| Sanofi | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Small Cell Lung Carcinoma | 12 |
| Lung Neoplasms | 1 |
| Neoplasm Metastasis | 1 |
| Neoplasms | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.